Rapid insertion integrated catheter and method of using an integrated catheter

Information

  • Patent Grant
  • 12097342
  • Patent Number
    12,097,342
  • Date Filed
    Monday, April 29, 2019
    5 years ago
  • Date Issued
    Tuesday, September 24, 2024
    a month ago
Abstract
An integrated catheter assembly for rapid vascular insertion including a catheter configured for receipt of a needle and a guidewire; a catheter assembly comprising an integrated assembly comprising a catheter, needle, and guidewire; and a method of rapidly inserting a catheter to obtain vascular access. The catheter includes a central lumen for receiving the needle and guidewire. The lumen includes a distal port and a transverse side port adjacent an intermediate portion thereof which provide open vascular communication from two ports between the central lumen and the vasculature. The needle and guidewire, when integrated with the catheter, extend through the transverse side port wherein a proximal end of the needle extends contiguous to and exterior of a proximal portion of the catheter.
Description
FIELD OF THE INVENTION

The present invention is directed to a venous catheter and the method of using the venous catheter, generally, and, more specifically, to a venous catheter assembly with a catheter configured for receipt of an integrated needle and guidewire for rapid insertion and the method of using the integrated catheter.


BACKGROUND OF THE INVENTION

Venous catheters, including central, peripheral, and so-called “midline” or extended-dwell peripheral venous catheters, are used in the medical environment to provide intravenous vascular access. Vascular access by venous catheters provides an expedient and highly effective means for drug administration, other fluid administration, chemotherapy, blood sampling, blood pressure monitoring, and parenteral nutrition, for example. These procedures often require that the catheter be left indwelling in the patient for an extended period of time. In a hospital setting, venous catheters are widely used in emergency departments, intensive care units, and operating rooms. In such settings, it is imperative that the venous catheters be very quickly and correctly positioned intravenously within the patient to obtain vascular access particularly in critical situations requiring rapid administration of medicines.


Highly effective and commonly used venous catheters are triple lumen catheters which are intravenously positioned within any venous structure, including the internal/external jugular, subclavian, or, femoral vein. Triple lumen catheters commonly include a central lumen which extends from the proximal end adjacent the user to the distal end which is positioned within the venous system. Two additional lumens may extend from the proximal end and terminate at a location adjacent to, but proximally removed from, the distal end of the catheter and terminate in open side ports. U.S. Pat. No. 7,311,697 B2 is an exemplary triple lumen catheter.


A widely accepted and commonly used percutaneous entry technique used to obtain access to the venous system of a patient requiring a venous catheter is a landmark guided technique known as the Seldinger technique. The Seldinger technique involves multiple steps which must be employed in medical conditions necessitating expedient placement of a line, such as in an emergency setting. In the Seldinger technique, the, physician makes an oblique entry with a hollow needle through the patient's skin, at a peripheral location using landmark guidance, and into a vein. The commonly used Seldinger technique is most often employed in combination with imaging guidance (e.g., ultrasound). Landmark guidance techniques involve visually or palpably locating anatomical landmarks for locating the targeted vein. For example, for subclavian vein entry, the landmark guided technique includes locating the junction of the middle and proximal third of the clavicle and inserting the needle at that location.


A blunt guidewire is then passed through the central lumen of the needle, and then the needle is withdrawn and removed leaving the guidewire within the vein. Next, a dilating device s passed over the guidewire to slightly enlarge the tract originally produced by the needle and, if warranted, multiple dilators having varying gauge, may be utilized, in a process called serial dilation. The dilator is then removed, leaving the guidewire within the vein. The catheter is then passed along the length and over the guidewire until positioned within the vein. Alternatively, use of a peel-away sheath may be used for placement of a catheter. The sheath may be utilized in conjunction with a dilator (also known as an introducer in this setting) for over-the-wire placement into the desired vessel. Once the sheath is within the vessel, the inner dilator (introducer) and wire are removed, allowing for placement of the catheter through the sheath's lumen. The sheath is then removed in a peel-away fashion, leaving only the catheter behind in the vessel. Blood may then be withdrawn from a catheter port to confirm the catheter placement within the vein. The guidewire is then removed from the vein.


With regard to initial percutaneous placement of the catheter, it is important to quickly position the venous catheter within the appropriate vein. This is imperative not only for the comfort of the patient, but also to achieve successful medical outcomes. Risks associated with incorrect catheter placement and multiple attempts at placement of the catheter include an increased risk of catheter related blood-stream infections from loss of sterility. In extreme instances, improper catheter placement may be injurious to adjacent structures such as the carotid artery, with serious consequences such as hemorrhage, stroke, or pseudo aneurysm formation. It is, thus, recognized that catheter placement may be assisted by utilizing real-time: ultrasound imaging techniques in order to minimize such complications. Additionally, high quality, portable ultrasound units have become more regularly available to physicians, thereby further facilitating the use of ultrasound assisted venous catheter placement. An exemplary method employing ultrasound guided central venous catheter placement is U.S. Publication. No. WO 2014006403 A1. More recently, vascular access devices have expanded to include midline catheters, or extended dwell peripheral intravenous lines. Midline catheters are longer and more durable than traditional peripheral intravenous catheters. Different than central catheters, midline catheters do not terminate in the vena cava or right atrium. However, they are typically placed in the larger veins of the upper extremity such as the radial, cephalic, median, brachial or basilicvein. Owing to their durability and location, midline catheters can remain in place longer than the traditional 2-3 days for a peripheral intravenous catheter without the same risks of infiltration and infection. Additionally, because of their size and insertion location, midline catheters are inserted using a combination needle puncture and over-the-wire access and insertion procedure. Although this differs somewhat from the Seldinger technique used for central catheters, it lends itself to benefit from the design and procedure described herein.


SUMMARY OF THE INVENTION

The present invention overcomes shortcomings of the prior art by providing a catheter assembly having a catheter configured for receipt of a needle and guidewire along an outer side surface for rapid insertion of the catheter assembly. Preferably, the venous placement of the catheter is facilitated with ultrasound guided techniques. The integrated catheter, that is, a catheter configured for receipt of a needle and guidewire which, according to one aspect, may be pre-assembled, includes at least a lumen for receipt of a transversely inserted needle which extends axially along the length of a distal portion of the lumen. The lumen extends from the proximal to the distal end of the catheter. Preferably one or more additional lumens, or “non-needle” lumens, are provided and extend from the catheter proximal end and terminate at side ports adjacent the catheter distal end. An additional side port, positioned proximal to the one or more non-needle side ports, is also provided on the catheter body and provides a port for receipt of the needle from an outer side surface of the catheter body, substantially in a transverse direction. The needle receiving side port defines the terminal end of a transverse channel which provides an open channel from the needle receiving side port to the needle lumen. According to another aspect of the present invention, the catheter may, therefore, be pre-assembled so as to include the needle and guidewire wherein the needle and the guidewire extend adjacent to and exterior of a proximal side portion of the catheter.


The method of using the catheter assembly according to the present invention includes the steps of pre-assembling the needle and guidewire within the catheter's needle side port to form an integrated catheter assembly; inserting the needle into the patient's venous system, preferably using ultrasound guidance; introducing the guidewire distally along the length of the needle and into the vessel; removing the needle; advancing the catheter distally along the length of the guidewire until positioned within the venous system; removing the guidewire; and confirming proper placement of the catheter. It is also within the scope of the presently described method to advance or remove the needle and guidewire together in the same method step as opposed to independently removing each. Accordingly, the present invention obviates several method steps of the prior Seldinger technique. Specifically, the catheter assembly according to preferred embodiments, utilizes ultrasound guidance to prevent inaccurate catheter placement. Medical complications are minimized and proper positioning of the catheter is expeditiously accomplished for rapid medical administration. Moreover, the integrated catheter assembly obviates the need for the additional steps of dilating the incision with a dilator(s) in that the catheter of the present invention is self-dilating. According to one aspect of the invention, use of stylets in multi-lumen catheters are selectively used to enhance the rigidity of the assembly and its ability to self-dilate. The integrated catheter of the present invention provides a pre-assembled guidewire within the needle thereby eliminating the need to thread the guidewire though the needle once vascular access is obtained and threading the catheter over the guidewire.


Numerous benefits are achieved by the integrated catheter assembly according to the present invention including a novel catheter for transversely receiving a needle and guidewire which may be pre-assembled in an integrated catheter assembly. One significant benefit is a marked decrease in the time required to percutaneously position the catheter within in a vessel lumen to achieve endovascular access with the catheter due to the elimination of conventional method steps involving the exchange of individual components according to the Seldinger technique. This allows for rapid insertion of the catheter and, hence, rapid administration of medicines or other substances. The pre-assembled integrated catheter assembly obviates the need to provide the discrete units of: catheter, needle, guidewire and a dilator. This eliminates the step of inserting the needle, threading the guidewire within the needle, and positioning the catheter along the guidewire. There is also a decreased risk of the loss of venous access which may occur with prior art methods of exchanging multiple components. The integrated catheter assembly of the present invention also obturates the catheter lumens and prevents complications of air embolism and limits blood loss. The additional needle side port of the catheter, once vacated by the needle and guidewire, beneficially provides an additional port for more rapid administration of greater amounts of medicines or other fluids and provides an additional administration port should the distal port become occluded. The integrated catheter assembly also does not require a separate dilator as the configuration of the various components presents a self-dilating integrated catheter assembly. By decreasing the number of method steps necessary for effective catheter insertion and by eliminating multiple assembly component exchanges over the guidewire, the catheter assembly and method according to the present invention beneficially reduces the risk of catheter related infection; thereby resulting in improved medical outcomes. These and other objectives are met by the present invention.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of the integrated catheter according to the present invention;



FIG. 2 is a cross-sectional view taken along line 2-2 of FIG. 1;



FIG. 3 is an enlarged, partially broken away, view of a needle side port according to the present invention;



FIG. 4A is a cross sectional view of the catheter taken along line 4A in FIG. 3;



FIG. 4B is a cross sectional view according to an alternative aspect of the present invention;



FIG. 4C is a cross sectional view according to another alternative aspect of the present invention;



FIG. 5 is a schematic illustration of a method step of inserting the integrated catheter;



FIG. 6 is a schematic illustration of a subsequent method step of endovascular deployment of the guidewire into the vessel lumen;



FIG. 7 is a schematic illustration of a subsequent method step of endovascular insertion of the catheter over the needle and guidewire;



FIG. 8 is a schematic illustration of a subsequent method step of removal of the needle and guidewire from the vessel lumen and the catheter needle side port;



FIG. 9 is an enlarged perspective view of the needle tip;



FIG. 10 is a perspective view, partially broken away, of the needle and guidewire; and



FIG. 11 is a hemostatic valve according to another aspect of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

The present invention will now be described in detail hereinafter by reference to the accompanying drawings. The invention is not intended to be limited to the embodiments described; rather, this detailed description is provided to enable any person skilled in the art to make and practice the invention.


The venous catheter assembly 10, as shown in FIG. 1, is used for surgical procedures in which a catheter is inserted percutaneously into the blood vessel for treatment. This treatment may include, for example, the administration of medicine or other fluids, blood pressure monitoring, and/or blood sampling. This invention is not limited to these uses, as it is within the scope of the present invention to provide a catheter for intravascular access, including, but not limited to, a central, midline or peripheral venous catheter. As is known in the art, the venous catheter as described herein may be used with any cavitary or luminal structure, including any vein. For the sake of discussion, the detailed description herein addresses use of the catheter assembly with any vein. As used herein, the terms “proximal” and “distal” are used to refer to the axial ends of the catheter assembly and various components. The term “proximal end” refers to the end closely adjacent the user of the assembly and the term “distal end” refers to the end of the catheter assembly that is percutaneously inserted into the patient, i.e., adjacent the needle tip. According to the invention illustrated in the various Figures, excluding horizontal cross-sections, the proximal end is toward the right and the distal end is toward the left. Also as used herein, the “axial direction” refers to the longitudinal axis of the catheter from the proximal end to the distal end. The term “transverse” direction refers to a direction which intersects the longitudinal axis, at any angle.


The venous catheter assembly 10 includes, generally, a novel catheter 12, a needle 14, and a guidewire 15. The catheter assembly 10 illustrated includes three lumens 16, 18, and 20, shown in FIG. 2. Each lumen provides a passageway for the ingress of fluids to or the egress of blood from the vascular system. Although venous catheters may have only a single lumen, such as lumen 20 which extends longitudinally from the proximal end adjacent the user to the distal end for venous insertion, it is more common to provide more than one lumen. Two or three (or more) lumen catheters are commonly utilized for diverse uses of a venous line. Multiple lumens also provide alternative administration or aspiration lumens should more than one lumen be used simultaneously or should one of the other lumens become occluded. The present invention relates to such single or multiple lumen catheters and a catheter assembly including the catheter. FIG. 4 illustrates a triple lumen catheter 12 as described herein in connection with the various other Figures. FIG. 4A, taken along line 4A-4A in FIG. 3, illustrates the cross-sectional view of the catheter assembly 10 according to one aspect of the present invention. FIG. 4A also illustrates a stylet 35 in one lumen, 16, which may selectively be positioned in any of the lumens. (It is noted that FIG. 3 does not include the stylet 35.) FIGS. 4B and 4C illustrate alternative aspects of the present invention. FIG. 4B illustrates a triple lumen catheter 12 including lumens 16, 18 and 20 which are differently positioned within the catheter 12. This is exemplary of various lumen positions contemplated by the present invention. FIG. 4C illustrates a double lumen catheter including the needle lumen 20 and one additional non-needle lumen 16. According to any of these aspects, a stylet 35 may be inserted into one or more of the lumens. Moreover, any known method of providing increased column strength may be utilized without departing from the spirit and scope of the present invention. This includes providing strengthening materials such as beads, coils or wires into the “dead space” (spaced within the catheter exterior to any of the lumens). According to the present invention, it may be desirable to include the stylet 35 into either or all of the non-needle receiving lumens, 16 and/or 18, which extends beyond the lumen side port 22 and/or 23.


The lumen 20 extends the length of the catheter and is configured to receive the needle 14. The one or more additional lumens, 16 and 18 as shown, are referred to as “non-needle lumens”. The non-needle lumens 16 and 18 each terminate at a respective side port 22, 23, defined by the catheter outer wall. According to the present invention, a needle side port 25 is also provided as will be described in greater detail below. The side ports 22, 23 of the non-needle lumens 16, 18 establishes intravenous communication of the catheter lumens 16, 18. As such, medicine and/or fluids may be introduced into the catheter, pass through the lumens, and exit the side ports to the vessel in which the catheter has been placed.


Preferably, side ports 22, 23 and 25 are longitudinally separated along the length of the catheter 12. As shown, the needle port 25 is positioned proximal to the non-needle ports 22, 23. This is exemplary, and it is within the scope of the present invention for the needle port to be distally positioned relative to one or more of the other side ports. The distance between the ports 22, 23, 25 is selected in proportion to the catheter's French size so as to axially separate distribution ports wherein multiple fluids may be substantially simultaneously administered through the various lumens. Additionally, the side ports are preferably oriented in a spiral or helical configuration along the catheter body to further separate distribution ports and to sustain the structural integrity of the catheter, particularly during insertion thereof. This configuration also is preferable to avoid multiple ports from becoming simultaneously occluded such as contact with a vessel wall or other intravascular structure. It is envisioned, however, that the various ports may be positioned along that same general side of the catheter and linearly as well.


The venous catheter assembly 10 of the illustrated embodiment is a triple lumen catheter. It is within the scope of the present invention, however, to provide a single lumen 20 and one or more additional non-needle lumens. As shown in FIG. 2, the lumen 20 extends from the proximal end to the distal end of the catheter 12 body. Two additional lumens 16, 18 are shown and each lumen is independent and not communicative with the other lumens 16, 18, 20. The catheter 12 further includes, in the illustrated embodiment, entry ports 26, 27, and 28 which communicate with a respective lumen 16, 18, 20 for the administration of or extraction of fluids or blood. As is known in the art, entry ports 26, 27, 28 may be manipulated to selectively occlude communication of the exterior environment with the lumens. Extension tubes 29, 30, 31 connect the entry ports to a respective lumen and may be of any desired length. Side clamps, not shown, may also be provided along the extension tubes as is known in the art to control the fluid flow through the lumen. As to one aspect of the present invention, a hub 33 joins distal ends of the extension tubes 29, 30, 31 to the proximal end of the catheter 12 to establish communication between the extension tubes and the respective lumen. The hub 33 is provided with a pair of radially extending wings which are advantageously used to further secure the catheter in place with sutures or adhesive-type devices applied to the skin (such as StatLock®).


A stylet 35 in the form of flexible or semi-rigid material, as shown, is provided within one or both non-needle lumens 16, 18 according to an alternative aspect of the present invention. The stylet 35 may likewise be positioned with the needle-receiving lumen 20. Such materials that may be utilized for the stylet include, but are not limited to, solid, hollow, or wire-like plastic or other polymeric material or metal or other alloy (for example, in a tubular configuration). As shown in FIGS. 1 and 4A, lumen 16 comprises a stylet 35 which is selectively inserted into the lumen 16 to improve rigidity in the form of column strength to the catheter. The amount of column strength required and, hence the number and kind of stylet(s), may vary from patient to patient and procedure to procedure. As shown, the stylet 35 extends substantially the axial length of the catheter 12, but it is within the scope of the present invention to provide a stylet within only a portion of the lumen 16. The stylet 35 provides structural rigidity to the catheter 12 which is important as the catheter 12 is percutaneously advanced through the skin, subcutaneous tissues, and blood vessel wall. This is referred to as the catheters “pushability”, or ability to possess sufficient rigidity so as to be percutaneously inserted and yet not too rigid so as to cause injury to the vein or surrounding perivascular structures. Moreover, the catheter 12 must remain substantially flexible and pliable for insertion into the venous system. While not being bound by any particular theory, it is believed that the stylet as shown, in combination with the catheter 12 construction, provides sufficient column strength to the catheter 12 for its application while also providing sufficient flexibility for introduction of the catheter into the venous system of a patient. The stylet is to be removed once the catheter is secured in place.


The catheter body 12 defines a novel side port 25 which, as shown, is positioned along the length of the catheter at a position proximal to the non-needle lumen side ports 22, 23. A transverse channel 36 extends from the side port 25 to the lumen 20 to provide open communication there between. As shown in FIG. 3, the transverse channel 36 is angularly positioned relative to the lumen axis and extends transversely with respect thereto. More specifically, the transverse channel 36 as shown extends at an acute angle relative the lumen axis. It is preferred that the angular orientation of the transverse channel 36 be at least approximately 90 degrees or less due to the envisioned angle of needle insertion. The side port 25 is sized, configured and positioned to receive the needle 14.


The catheter assembly 10 may be advantageously provided to include the catheter 12 with a pre-assembled needle 14 and guidewire 15 inserted within the side port 25. As such, the needle 14 extends within a distal portion of the lumen 20 and out the distal tip 38 of the catheter 12. Accordingly, a proximal portion of the needle 14 is contiguous with an outer proximal portion of the catheter, transverse to the lumen axis, while a distal portion of the needle 14 extends co-axially within the lumen 20.


As shown in FIG. 9, the needle 14 has an insertion tip 37 which is preferably beveled. The gradual taper of the bevel facilitates dilation through the soft tissues and vessel wall for the needle 14 and simultaneously dilates the soft tissues and vessel wall for the catheter 12 insertion. The needle 14 is hollow and may be formed of a surgical grade stainless steel, such as an 18-22 gauge, as is common in the art. As shown in the various Figures, the needle 14 is inserted (preferably prior to use) into the needle side port 25, extends along the length of the transverse channel 36 and enters the lumen 20. The needle 14 extends through a distal aperture on the distal tip 38 of the catheter 12. The distal aperture is preferably sized in accordance with the needle gauge wherein only minimal tolerances are provided for smooth trackability. Preferably, the needle 14 includes an etched portion in the form of a band to provide improved visualization when using ultrasound guidance.


As shown in FIG. 10, the guidewire 15 extends along the length of the hollow needle 14. The proximal end of the guidewire preferably includes visible marks at regular intervals, for example, 1 cm, to indicate the depth of the wire. This avoids placement too deep within the vasculature, but of sufficient depth for catheter placement. The guidewire 15 may be formed of material known in the art, such as surgical grade wire such as a composite with a nitinol core to provide a blend of stiffness and flexibility, for effective torque control and venous navigation.



FIG. 11 depicts a hemostatic valve 42 which may optionally be used as part of the integrated catheter assembly to facilitate aspiration of the side port 25 to confirm intravascular placement of the catheter 12. The hemostatic valve 42 may be particularly beneficial if ultrasound guided placement is not utilized. The hemostatic valve 42 may be fastened to the proximal hub 33 in a known manner and positioned over the guidewire.


The catheter 12 is a disposable, single use device that is made of a biocompatible material. The stylet, needle, and guidewire may be made of known materials, such as steel, nitinol, or a composition including one or both of these. As set forth above, the stylet 35 may be formed of a plastic or other polymeric or metallic material. The guidewire 15, according to one aspect, is formed of a flexible material to accommodate anatomical complications such as complex and tortuous vasculature. Commonly used materials are a polymeric coated or metallic wire.



FIGS. 5-8 are schematic illustrations of the method of utilizing the integrated catheter for rapid insertion. The integrated catheter assembly 10 is provided with the guidewire 15 positioned within the hollow needle 14 and the needle 14 is positioned within the side port 25. A proximal portion of the needle extends contiguous to and external of a proximal portion of the catheter 12. The distal portion of the needle 14 extends within and along the length of the transverse channel 36 and within and along the length of a distal portion of the lumen 20. The needle insertion tip 37 extends through the distal aperture of the catheter distal tip 38. As shown in FIG. 5, the needle insertion tip 37, preferably utilizing ultrasound guidance 44, penetrates the skin 56, subcutaneous tissue, and the vessel wall 57, entering the target vessel 58. As shown in FIG. 6, once penetration into the vessel is confirmed, by ultrasound or aspiration, endovascular deployment of the guidewire 15 is achieved. The physician advances the guidewire 15 by applying inward force on the proximal end of the guidewire 15, utilizing the visible markings thereon to determine depth of insertion. The physician, while fixing the needle 14 and wire 15 in place, advances the catheter over the needle and wire by applying downward pressure until the catheter 12, too, achieves intravascular placement as shown in FIG. 7.


As shown in FIG. 8, the needle 14 and the guidewire 15 are then withdrawn. According to another aspect of the present invention, the needle 14 and guidewire 15 may be removed together, in a single step. The guidewire 15 is then withdrawn and the catheter 12 has been rapidly inserted into the endovascular system. Particularly with the use of ultrasound guidance, this method enables the catheter assembly 10 and, hence, the catheter 12, to be properly and rapidly positioned within the vasculature, without requiring multiple steps of exchanging components as in prior art methods. Moreover, the integrity of the sterile environment is maintained by virtue of utilizing fewer independent components requiring additional and independent manipulation. While not being bound by any particular theory, it is believed that the speed of infusion through the lumen is increased due to the ability of fluids to enter the vasculature from two ports: one at the distal tip 38 and one at the side port 25. It is also believed that because the effective length of the catheter lumen is decreased, at least in part due to Poiseuille's law or other principles, the flow rate is further increased. The integrated catheter assembly 10 decreases the risk of loss of venous access which may occur in prior art methods as components are exchanged. Additionally, the integrated catheter, with one or more stylets, obturates all lumens and prevents complications of air embolism and limits blood loss during insertion.


Alternative embodiments of the present invention include use of specialized antithrombogenic or antibacterial surface coatings, or composites including these, for various components of the catheter assembly. The number of lumens may vary, based upon the intended clinical use. The novel method and catheter assembly according to the present invention may be employed for other vascular access devices and procedures, including, but not limited to, temporary dialysis catheters, peripherally inserted catheters, venous and arterial sheaths, and other vascular access lines or midline catheters. Moreover, the size of various components may be varied for diverse reasons, including, the age of patient, access site, and/or anatomy. A plurality of sizes and lengths may, therefore, be provided. The catheter may be formed of materials having varying stiffness. Conventional catheters are made of a 49 durometer material on the Shore D scale, although other materials or compositions having varying stiffness may be selected, depending upon the clinical need. As described herein, the catheter assembly according to the present invention preferably is positioned utilizing ultrasound guidance. Other guidance techniques, such as fluoroscopy and computed tomography may also be employed. Other guidance techniques, such as palpation, direct visualization, or anatomical landmarks, may also be used to position the catheter assembly according to the present invention.


While exemplary embodiments have been shown and described above for the purpose of disclosure, modifications to the disclosed embodiments may occur to those skilled in the art. The disclosure, therefore, is not limited to the above precise embodiments and that changes may be made without departing from its spirit and scope.

Claims
  • 1. An integrated catheter assembly for rapid insertion into a blood vessel, comprising: a needle having a guidewire disposed in a needle lumen; anda catheter having a first longitudinal length defined between a proximal end and a distal end, the catheter comprising: a longitudinally extending first lumen extending between the proximal end and the distal end, the first lumen terminating at a distal port in the distal end;a first lumen side port positioned between the proximal end and the distal end; anda generally cylindrical transverse channel having a predetermined length defined by a sidewall extending circumferentially around the first lumen side port to the first lumen at an angle transverse to a first lumen longitudinal axis, the needle and guidewire extending through the first lumen side port, the generally cylindrical transverse channel, and the distal port such that a tip of the needle extends past the distal end of the catheter and a proximal end of the needle and guidewire extend proximal to the first lumen side port for insertion of the catheter into a patient.
  • 2. The integrated catheter assembly according to claim 1, further comprising a second longitudinally extending lumen extending from the proximal end to a second lumen side port for providing fluid communication with the second lumen for fluid administration, wherein the second lumen side port is distal to the first lumen side port.
  • 3. The integrated catheter assembly according to claim 2, further comprising a third longitudinally extending lumen extending from the proximal end to a third lumen side port for providing open communication with the third lumen for fluid administration, wherein the third lumen side port is distal to the first lumen side port.
  • 4. The integrated catheter assembly according to claim 3, wherein the second lumen side port, the third lumen side port, and the first lumen side port are positioned in a helical configuration around the catheter.
  • 5. The integrated catheter assembly according to claim 1, wherein the generally cylindrical transverse channel extends from the first lumen at an acute angle.
  • 6. The integrated catheter assembly according to claim 1, wherein the catheter has a wall thickness defined between an outer surface and the first lumen, and wherein the predetermined length of the generally cylindrical transverse channel is greater than the wall thickness.
  • 7. The integrated catheter assembly according to claim 1, wherein the distal port is sized in accordance with a gauge of the needle.
  • 8. The integrated catheter assembly according to claim 1, wherein the needle includes an etched portion in the form of a band to provide improved visualization when using ultrasound guidance.
  • 9. The integrated catheter assembly according to claim 1, wherein the guidewire includes visible marks at regular intervals along a section proximal of the needle to indicate a depth of the guidewire when inserted through the needle after intravenous access.
  • 10. The integrated catheter assembly according to claim 1, wherein the guidewire is formed as a composite with a nitinol core.
  • 11. The integrated catheter assembly according to claim 1, further comprising a hemostatic valve configured to facilitate aspiration of the first lumen side port.
  • 12. The integrated catheter assembly according to claim 2, further comprising a stylet configured for insertion into the second lumen to provide increased column strength of the catheter.
  • 13. The integrated catheter assembly according to claim 3, further comprising a stylet configured for insertion into the third lumen to provide increased column strength of the catheter.
  • 14. The integrated catheter assembly according to claim 3, further comprising a first stylet configured for insertion into the second lumen, and a second stylet configured for insertion into the third lumen, the first stylet and the second stylet configured to provide increased column strength of the catheter.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation of and claims priority to U.S. application Ser. No. 15/008,628 filed Jan. 28, 2016 which claims priority to U.S. Provisional Patent Application Ser. No. 62/109,403 filed Jan. 29, 2015, the disclosures of which are hereby incorporated by reference.

US Referenced Citations (356)
Number Name Date Kind
1013691 Shields Jan 1912 A
3225762 Guttman Dec 1965 A
3382872 Rubin May 1968 A
3570485 Reilly Mar 1971 A
3890976 Bazell et al. Jun 1975 A
4205675 Vaillancourt Jun 1980 A
4292970 Hession, Jr. Oct 1981 A
4468224 Enzmann Aug 1984 A
4525157 Vaillancourt Jun 1985 A
4581019 Curelaru et al. Apr 1986 A
4594073 Stine Jun 1986 A
4702735 Luther et al. Oct 1987 A
4743265 Whitehouse et al. May 1988 A
4766908 Clement Aug 1988 A
4863432 Kvalo Sep 1989 A
4950252 Luther et al. Aug 1990 A
4994040 Cameron et al. Feb 1991 A
5017259 Kohsai May 1991 A
5040548 Yock Aug 1991 A
5057073 Martin Oct 1991 A
5112312 Luther May 1992 A
5115816 Lee May 1992 A
5120317 Luther Jun 1992 A
5158544 Weinstein Oct 1992 A
5188593 Martin Feb 1993 A
5195962 Martin et al. Mar 1993 A
5207650 Martin May 1993 A
5267958 Buchbinder et al. Dec 1993 A
5295970 Clinton Mar 1994 A
5306247 Pfenninger Apr 1994 A
5322512 Mohiuddin Jun 1994 A
5328472 Steinke et al. Jul 1994 A
5350358 Martin Sep 1994 A
5358495 Lynn Oct 1994 A
5368567 Lee Nov 1994 A
5378230 Mahurkar Jan 1995 A
5380290 Makower Jan 1995 A
5389087 Miraki Feb 1995 A
5439449 Mapes et al. Aug 1995 A
5443457 Ginn et al. Aug 1995 A
5460185 Johnson et al. Oct 1995 A
5489271 Andersen Feb 1996 A
5573520 Schwartz Nov 1996 A
5683370 Luther et al. Nov 1997 A
5718678 Fleming, III Feb 1998 A
5772636 Brimhall et al. Jun 1998 A
5885251 Luther Mar 1999 A
5919164 Andersen Jul 1999 A
5921971 Agro et al. Jul 1999 A
5947940 Beisel Sep 1999 A
5957893 Luther et al. Sep 1999 A
5971957 Luther et al. Oct 1999 A
6159198 Gardeski et al. Dec 2000 A
6206849 Martin et al. Mar 2001 B1
6228062 Howell et al. May 2001 B1
6475187 Gerberding Nov 2002 B1
6606515 Windheuser et al. Aug 2003 B1
6626869 Bint Sep 2003 B1
6716228 Tal Apr 2004 B2
6726659 Stocking et al. Apr 2004 B1
6819951 Patel et al. Nov 2004 B2
6821287 Jang Nov 2004 B1
6926692 Katoh et al. Aug 2005 B2
6962575 Tal Nov 2005 B2
6991625 Gately et al. Jan 2006 B1
6994693 Tal Feb 2006 B2
6999809 Currier et al. Feb 2006 B2
7025746 Tal Apr 2006 B2
7029467 Currier Apr 2006 B2
7037293 Carrillo et al. May 2006 B2
7074231 Jang Jul 2006 B2
7141050 Deal et al. Nov 2006 B2
7144386 Korkor et al. Dec 2006 B2
7311697 Osborne Dec 2007 B2
7364566 Elkins et al. Apr 2008 B2
7377910 Katoh May 2008 B2
7390323 Jang Jun 2008 B2
D600793 Bierman et al. Sep 2009 S
D601242 Bierman et al. Sep 2009 S
D601243 Bierman et al. Sep 2009 S
7594911 Powers et al. Sep 2009 B2
7691093 Brimhall Apr 2010 B2
7722567 Tal May 2010 B2
D617893 Bierman et al. Jun 2010 S
D624643 Bierman et al. Sep 2010 S
7819889 Healy Oct 2010 B2
7857788 Racz Dec 2010 B2
D630729 Bierman et al. Jan 2011 S
7909797 Kennedy, II et al. Mar 2011 B2
7909811 Agro et al. Mar 2011 B2
7922696 Tal et al. Apr 2011 B2
7938820 Webster May 2011 B2
7967834 Tal et al. Jun 2011 B2
7976511 Fojtik Jul 2011 B2
7985204 Katoh et al. Jul 2011 B2
8073517 Burchman Dec 2011 B1
8105286 Anderson et al. Jan 2012 B2
8192402 Anderson et al. Jun 2012 B2
8202251 Bierman et al. Jun 2012 B2
8206356 Katoh et al. Jun 2012 B2
8361011 Mendels Jan 2013 B2
8372107 Tupper Feb 2013 B2
8377006 Tal et al. Feb 2013 B2
8454577 Joergensen et al. Jun 2013 B2
8585858 Kronfeld et al. Nov 2013 B2
8657790 Tal et al. Feb 2014 B2
8672888 Tal Mar 2014 B2
8696645 Tal et al. Apr 2014 B2
8784362 Boutilette et al. Jul 2014 B2
8827958 Bierman et al. Sep 2014 B2
8876704 Golden et al. Nov 2014 B2
8882713 Call Nov 2014 B1
8900192 Anderson et al. Dec 2014 B2
8900207 Uretsky Dec 2014 B2
8915884 Tal et al. Dec 2014 B2
8956327 Bierman et al. Feb 2015 B2
9023093 Pal May 2015 B2
9067023 Bertocci Jun 2015 B2
9126012 McKinnon et al. Sep 2015 B2
9138252 Bierman et al. Sep 2015 B2
9180275 Helm Nov 2015 B2
9265920 Rundquist et al. Feb 2016 B2
9272121 Piccagli Mar 2016 B2
9445734 Grunwald Sep 2016 B2
9522254 Belson Dec 2016 B2
9554785 Walters et al. Jan 2017 B2
9566087 Bierman et al. Feb 2017 B2
9675784 Belson Jun 2017 B2
9713695 Bunch et al. Jul 2017 B2
9764117 Bierman et al. Sep 2017 B2
9770573 Golden et al. Sep 2017 B2
9814861 Boutillette et al. Nov 2017 B2
9820845 von Lehe et al. Nov 2017 B2
9861383 Clark Jan 2018 B2
9872971 Blanchard Jan 2018 B2
9884169 Bierman et al. Feb 2018 B2
9889275 Voss et al. Feb 2018 B2
9913585 McCaffrey et al. Mar 2018 B2
9913962 Tal et al. Mar 2018 B2
9981113 Bierman May 2018 B2
10010312 Tegels Jul 2018 B2
10065020 Gaur Sep 2018 B2
10086170 Chhikara et al. Oct 2018 B2
10098724 Adams et al. Oct 2018 B2
10111683 Tsamir et al. Oct 2018 B2
10118020 Avneri et al. Nov 2018 B2
10130269 McCaffrey et al. Nov 2018 B2
10220184 Clark Mar 2019 B2
10220191 Belson et al. Mar 2019 B2
10265508 Baid Apr 2019 B2
10271873 Steingisser et al. Apr 2019 B2
10376675 Mitchell et al. Aug 2019 B2
10675440 Abitabilo et al. Jun 2020 B2
10806901 Burkholz et al. Oct 2020 B2
10926060 Stern et al. Feb 2021 B2
11260206 Stone et al. Mar 2022 B2
11759607 Biancarelli Sep 2023 B1
20020040231 Wysoki Apr 2002 A1
20020198492 Miller et al. Dec 2002 A1
20030036712 Heh et al. Feb 2003 A1
20030060863 Dobak Mar 2003 A1
20030088212 Tal May 2003 A1
20030100849 Jang May 2003 A1
20030153874 Tal Aug 2003 A1
20030158514 Tal Aug 2003 A1
20040015138 Currier et al. Jan 2004 A1
20040064086 Gottlieb et al. Apr 2004 A1
20040116864 Boudreaux Jun 2004 A1
20040116901 Appling Jun 2004 A1
20040167478 Mooney et al. Aug 2004 A1
20040193093 Desmond Sep 2004 A1
20040230178 Wu Nov 2004 A1
20050004554 Osborne Jan 2005 A1
20050120523 Schweikert Jun 2005 A1
20050131343 Abrams et al. Jun 2005 A1
20050215956 Nerney Sep 2005 A1
20050245882 Elkins Nov 2005 A1
20050283221 Mann et al. Dec 2005 A1
20060009740 Higgins et al. Jan 2006 A1
20060116629 Tal et al. Jun 2006 A1
20060129100 Tal Jun 2006 A1
20060129130 Tal et al. Jun 2006 A1
20070276288 Khaw Nov 2007 A1
20080045894 Perchik et al. Feb 2008 A1
20080125744 Treacy May 2008 A1
20080125748 Patel May 2008 A1
20080132850 Fumiyama et al. Jun 2008 A1
20080262430 Anderson et al. Oct 2008 A1
20080262431 Anderson et al. Oct 2008 A1
20080294111 Tal et al. Nov 2008 A1
20080312578 Defonzo Dec 2008 A1
20080319387 Amisar et al. Dec 2008 A1
20090187147 Kurth et al. Jul 2009 A1
20090221961 Tal et al. Sep 2009 A1
20090270889 Tal et al. Oct 2009 A1
20090292272 McKinnon Nov 2009 A1
20100030154 Duffy Feb 2010 A1
20100256487 Hawkins et al. Oct 2010 A1
20100298839 Castro Nov 2010 A1
20100305474 DeMars et al. Dec 2010 A1
20110004162 Tal Jan 2011 A1
20110009827 Bierman et al. Jan 2011 A1
20110021994 Anderson et al. Jan 2011 A1
20110066142 Tal et al. Mar 2011 A1
20110071502 Asai Mar 2011 A1
20110144620 Tal Jun 2011 A1
20110152836 Riopelle et al. Jun 2011 A1
20110202006 Bierman et al. Aug 2011 A1
20110251559 Tal et al. Oct 2011 A1
20110270192 Anderson et al. Nov 2011 A1
20120041371 Tal et al. Feb 2012 A1
20120065590 Bierman et al. Mar 2012 A1
20120078231 Hoshinouchi Mar 2012 A1
20120130411 Tal et al. May 2012 A1
20120130415 Tal et al. May 2012 A1
20120157854 Kurrus Jun 2012 A1
20120215171 Christiansen Aug 2012 A1
20120220942 Hall et al. Aug 2012 A1
20120226239 Green Sep 2012 A1
20120283640 Anderson et al. Nov 2012 A1
20120316500 Bierman et al. Dec 2012 A1
20130053763 Makino et al. Feb 2013 A1
20130053826 Shevgoor Feb 2013 A1
20130123704 Bierman et al. May 2013 A1
20130158338 Kelly Jun 2013 A1
20130188291 Vardiman Jul 2013 A1
20130237931 Tal et al. Sep 2013 A1
20130306079 Tracy Nov 2013 A1
20140025036 Bierman et al. Jan 2014 A1
20140081210 Bierman et al. Mar 2014 A1
20140094774 Blanchard Apr 2014 A1
20140100552 Gallacher et al. Apr 2014 A1
20140207052 Tal et al. Jul 2014 A1
20140207069 Bierman et al. Jul 2014 A1
20140214005 Belson Jul 2014 A1
20140257111 Yamashita et al. Sep 2014 A1
20140276432 Bierman et al. Sep 2014 A1
20140276599 Cully Sep 2014 A1
20150011834 Ayala Jan 2015 A1
20150080939 Adams et al. Mar 2015 A1
20150094653 Pacheco et al. Apr 2015 A1
20150112307 Margolis Apr 2015 A1
20150112310 Call et al. Apr 2015 A1
20150126930 Bierman et al. May 2015 A1
20150148595 Bagwell May 2015 A1
20150190168 Bierman et al. Jul 2015 A1
20150196210 McCaffrey et al. Jul 2015 A1
20150224287 Bian et al. Aug 2015 A1
20150231364 Blanchard et al. Aug 2015 A1
20150283357 Lampropoulos et al. Oct 2015 A1
20150297868 Tal et al. Oct 2015 A1
20150320969 Haslinger et al. Nov 2015 A1
20150320977 Vitullo et al. Nov 2015 A1
20150351793 Bierman et al. Dec 2015 A1
20150359549 Lenker et al. Dec 2015 A1
20150359998 Carmel et al. Dec 2015 A1
20160082223 Barnell Mar 2016 A1
20160114124 Tal Apr 2016 A1
20160158523 Helm Jun 2016 A1
20160220786 Mitchell et al. Aug 2016 A1
20160242661 Fischell Aug 2016 A1
20160256101 Aharoni Sep 2016 A1
20160325073 Davies et al. Nov 2016 A1
20160338728 Tal Nov 2016 A1
20160346503 Jackson et al. Dec 2016 A1
20170035990 Swift Feb 2017 A1
20170072165 Lim et al. Mar 2017 A1
20170120000 Osypka et al. May 2017 A1
20170120014 Harding et al. May 2017 A1
20170120034 Kaczorowski May 2017 A1
20170128700 Roche Rebollo May 2017 A1
20170156987 Babbs et al. Jun 2017 A1
20170172653 Urbanski Jun 2017 A1
20170239443 Abitabilo et al. Aug 2017 A1
20170259043 Chan et al. Sep 2017 A1
20170273713 Shah et al. Sep 2017 A1
20170296792 Ornelas Vargas et al. Oct 2017 A1
20170326339 Bailey et al. Nov 2017 A1
20170361070 Hivert Dec 2017 A1
20170368255 Provost et al. Dec 2017 A1
20180001062 O'Carrol et al. Jan 2018 A1
20180021545 Mitchell et al. Jan 2018 A1
20180116690 Sarabia et al. May 2018 A1
20180117284 Appling et al. May 2018 A1
20180133438 Hulvershorn et al. May 2018 A1
20180154062 DeFonzo et al. Jun 2018 A1
20180154112 Chan et al. Jun 2018 A1
20180214674 Ebnet et al. Aug 2018 A1
20180296799 Horst et al. Oct 2018 A1
20180296804 Bierman Oct 2018 A1
20180310955 Lindekugel et al. Nov 2018 A1
20190015646 Matlock et al. Jan 2019 A1
20190021640 Burkholz et al. Jan 2019 A1
20190060616 Solomon Feb 2019 A1
20190076167 Fantuzzi et al. Mar 2019 A1
20190134349 Cohn et al. May 2019 A1
20190192824 Cordeiro et al. Jun 2019 A1
20190201665 Turpin Jul 2019 A1
20190209812 Burkholz et al. Jul 2019 A1
20190255294 Mitchell et al. Aug 2019 A1
20190255298 Mitchell et al. Aug 2019 A1
20190275303 Tran et al. Sep 2019 A1
20190276268 Akingba Sep 2019 A1
20190321590 Burkholz et al. Oct 2019 A1
20200001051 Huang et al. Jan 2020 A1
20200016374 Burkholz et al. Jan 2020 A1
20200046948 Burkholz et al. Feb 2020 A1
20200100716 Devgon et al. Apr 2020 A1
20200129732 Vogt et al. Apr 2020 A1
20200147349 Holt May 2020 A1
20200197682 Franklin et al. Jun 2020 A1
20200197684 Wax Jun 2020 A1
20200237278 Asbaghi Jul 2020 A1
20200359995 Walsh et al. Nov 2020 A1
20210030944 Cushen et al. Feb 2021 A1
20210069471 Howell Mar 2021 A1
20210085927 Howell Mar 2021 A1
20210100985 Akcay et al. Apr 2021 A1
20210113809 Howell Apr 2021 A1
20210113810 Howell Apr 2021 A1
20210113816 DiCianni Apr 2021 A1
20210121661 Howell Apr 2021 A1
20210121667 Howell Apr 2021 A1
20210228842 Scherich et al. Jul 2021 A1
20210228843 Howell et al. Jul 2021 A1
20210244920 Kujawa et al. Aug 2021 A1
20210290898 Burkholz Sep 2021 A1
20210290901 Burkholz et al. Sep 2021 A1
20210290913 Horst et al. Sep 2021 A1
20210322729 Howell Oct 2021 A1
20210330941 Howell et al. Oct 2021 A1
20210330942 Howell Oct 2021 A1
20210361915 Howell et al. Nov 2021 A1
20210402149 Howell Dec 2021 A1
20210402153 Howell et al. Dec 2021 A1
20220001138 Howell Jan 2022 A1
20220032013 Howell et al. Feb 2022 A1
20220032014 Howell et al. Feb 2022 A1
20220062528 Thornley et al. Mar 2022 A1
20220126064 Tobin et al. Apr 2022 A1
20220193376 Spataro et al. Jun 2022 A1
20220193377 Haymond et al. Jun 2022 A1
20220193378 Spataro et al. Jun 2022 A1
20220323723 Spataro et al. Oct 2022 A1
20220331563 Papadia Oct 2022 A1
20230042898 Howell et al. Feb 2023 A1
20230096377 West et al. Mar 2023 A1
20230096740 Bechstein et al. Mar 2023 A1
20230099654 Blanchard et al. Mar 2023 A1
20230100482 Howell Mar 2023 A1
20230101455 Howell et al. Mar 2023 A1
20230102231 Bechstein et al. Mar 2023 A1
20230233814 Howell et al. Jul 2023 A1
20240009427 Howell et al. Jan 2024 A1
20240050706 Howell et al. Feb 2024 A1
20240198058 Howell et al. Jun 2024 A1
Foreign Referenced Citations (104)
Number Date Country
202012006191 Jul 2012 DE
0653220 May 1995 EP
0730880 Sep 1996 EP
2061385 May 2009 EP
1458437 Mar 2010 EP
2248549 Nov 2010 EP
2319576 May 2011 EP
2366422 Sep 2011 EP
2486880 Aug 2012 EP
2486881 Aug 2012 EP
2486951 Aug 2012 EP
2512576 Oct 2012 EP
2152348 Feb 2015 EP
3473291 Apr 2019 EP
3093038 May 2019 EP
2260897 Sep 2019 EP
3693051 Aug 2020 EP
1273547 May 1972 GB
2004248987 Sep 2004 JP
2008054859 Mar 2008 JP
9421315 Sep 1994 WO
9532009 Nov 1995 WO
9844979 Oct 1998 WO
9853871 Dec 1998 WO
9912600 Mar 1999 WO
9926681 Jun 1999 WO
0006221 Feb 2000 WO
0054830 Sep 2000 WO
2003008020 Jan 2003 WO
2003057272 Jul 2003 WO
03068073 Aug 2003 WO
2003066125 Aug 2003 WO
2005096778 Oct 2005 WO
2006055288 May 2006 WO
2006055780 May 2006 WO
2007046850 Apr 2007 WO
2008033983 Mar 2008 WO
2008092029 Jul 2008 WO
2008131300 Oct 2008 WO
2008131289 Oct 2008 WO
2009114833 Sep 2009 WO
2009114837 Sep 2009 WO
2010048449 Apr 2010 WO
2010056906 May 2010 WO
2010083467 Jul 2010 WO
2010132608 Nov 2010 WO
2011081859 Jul 2011 WO
2011097639 Aug 2011 WO
2011109792 Sep 2011 WO
2011146764 Nov 2011 WO
2012068162 May 2012 WO
2012068166 May 2012 WO
2012135761 Oct 2012 WO
2012154277 Nov 2012 WO
2012162677 Nov 2012 WO
2013026045 Feb 2013 WO
2013138519 Sep 2013 WO
2014006403 Jan 2014 WO
2014100392 Jun 2014 WO
2014113257 Jul 2014 WO
2014152005 Sep 2014 WO
2014197614 Dec 2014 WO
2015057766 Apr 2015 WO
2015077560 May 2015 WO
2015168655 Nov 2015 WO
2016110824 Jul 2016 WO
2016123278 Aug 2016 WO
2016139590 Sep 2016 WO
2016139597 Sep 2016 WO
2016178974 Nov 2016 WO
2016176065 Nov 2016 WO
2016187063 Nov 2016 WO
2018089275 May 2018 WO
2018089285 May 2018 WO
2018089385 May 2018 WO
2018191547 Oct 2018 WO
2018213148 Nov 2018 WO
2018218236 Nov 2018 WO
2019050576 Mar 2019 WO
2019146026 Aug 2019 WO
2019199734 Oct 2019 WO
2020014149 Jan 2020 WO
2020069395 Apr 2020 WO
2020109448 Jun 2020 WO
2020113123 Jun 2020 WO
2021050302 Mar 2021 WO
2021062023 Apr 2021 WO
2021077103 Apr 2021 WO
2021081205 Apr 2021 WO
2021086793 May 2021 WO
2021236950 Nov 2021 WO
2022031618 Feb 2022 WO
2022094141 May 2022 WO
2022133297 Jun 2022 WO
2022-140406 Jun 2022 WO
2022140429 Jun 2022 WO
2022217098 Oct 2022 WO
2023014994 Feb 2023 WO
2023049498 Mar 2023 WO
2023049505 Mar 2023 WO
2023049511 Mar 2023 WO
2023049519 Mar 2023 WO
2023049522 Mar 2023 WO
2023146792 Aug 2023 WO
Non-Patent Literature Citations (74)
Entry
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Final Office Action dated May 30, 2018.
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Non-Final Office Action dated Jan. 25, 2019.
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Non-Final Office Action dated Nov. 2, 2017.
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Notice of Allowance dated May 15, 2019.
PCT/US2020/048583 filed Aug. 28, 2020 International Search Report and Written Opinion dated Nov. 13, 2020.
PCT/US2020/052536 filed Sep. 24, 2020 International Search Report and Written Opinion dated Dec. 4, 2020.
PCT/US2020/056364 filed Oct. 19, 2020 International Search Report and Written Opinion dated Jan. 19, 2021.
PCT/US2020/056864 filed Oct. 22, 2020 International Search Report and Written Opinion dated Jan. 14, 2021.
PCT/US2020/057202 filed Oct. 23, 2020 International Search Report and Written Opinion dated Jan. 21, 2021.
PCT/US2020/057397 filed Oct. 26, 2020 International Search Report and Written Opinion dated Mar. 10, 2021.
PCT/US2021/014700 filed Jan. 22, 2021 International Search Report and Written Opinion dated Jun. 29, 2021.
PCT/US2021/028018 filed Apr. 19, 2021 International Search Report and Written Opinion dated Sep. 13, 2021.
PCT/US2021/028683 filed Apr. 22, 2021 International Search Report and Written Opinion dated Sep. 16, 2021.
PCT/US2021/029183 filed Apr. 26, 2021 International Search Report and Written Opinion dated Sep. 24, 2021.
PCT/US2021/033443 filed May 20, 2021 International Search Report and Written Opinion dated Sep. 23, 2021.
PCT/US2021/028018 filed Apr. 19, 2021 International Preliminary Report on Patentability dated Jun. 3, 2022.
PCT/US2021/064174 filed Dec. 17, 2021 International Search Report and Written Opinion dated May 18, 2022.
PCT/US2021/064642 filed Dec. 21, 2021 International Search Report and Written Opinion dated May 11, 2022.
U.S. Appl. No. 17/031,478, filed Sep. 24, 2020 Non-Final Office Action dated May 11, 2022.
U.S. Appl. No. 17/006,553, filed Aug. 28, 2020 Non-Final Office Action dated Mar. 16, 2022.
U.S. Appl. No. 17/077,728, filed Oct. 22, 2020 Non-Final Office Action dated Feb. 9, 2022.
PCT/US2022/039614 filed Aug. 5, 2022 International Search Report and Written Opinion dated Dec. 22, 2022.
PCT/US2022/044848 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 3, 2023.
PCT/US2022/044918 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 21, 2023.
PCT/US2022/044923 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 15, 2023.
U.S. Appl. No. 17/237,909, filed Apr. 22, 2021 Restriction Requirement dated Feb. 1, 2023.
U.S. Appl. No. 17/326,017, filed May 20, 2021 Non-Final Office Action dated Jan. 26, 2023.
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Mar. 2, 2023.
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Notice of Allowance dated Aug. 9, 2023.
U.S. Appl. No. 17/237,909, filed Apr. 22, 2021 Non-Final Office Action dated Jul. 27, 2023.
U.S. Appl. No. 17/326,017, filed May 20, 2021 Notice of Allowance dated Jul. 3, 2023.
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Restriction Requirement dated Jul. 20, 2023.
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Final Office Action dated Jul. 27, 2023.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Non-Final Office Action dated Jul. 17, 2023.
PCT/US2022/024085 filed Apr. 8, 2022 International Search Report and Wirtten Opinion dated Sep. 12, 2022.
U.S. Appl. No. 17/031,478, filed Sep. 24, 2020 Notice of Allowance dated Sep. 16, 2022.
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Non-Final Office Action dated Oct. 25, 2022.
PCT/US2021/039084 filed Jun. 25, 2021 International Search Report and Written Opinion dated Jan. 10, 2022.
PCT/US2021/044029 filed Jul. 30, 2021 International Search Report and Written Opinion dated Dec. 9, 2021.
PCT/US2021/044223 filed Aug. 2, 2021 International Search Report and Written Opinion dated Dec. 21, 2021.
PCT/US2021/048275 filed Aug. 30, 2021 International Search Report and Written Opinion dated Jan. 4, 2022.
PCT/US2021/057135 filed Oct. 28, 2021 International Search Report and Written Opinion dated Mar. 11, 2022.
PCT/US2021/064671 filed Dec. 21, 2021 International Search Report and Written Opinion dated May 27, 2022.
PCT/US2022/044879 filed Sep. 27, 2022 International Search Report and Written Opinion dated Mar. 3, 2023.
PCT/US2022/044901 filed Sep. 27, 2022 International Search Report and Written Opinion dated Mar. 3, 2023.
U.S. Appl. No. 17/237,909, filed Apr. 22, 2021 Notice of Allowance dated Oct. 27, 2023.
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Final Office Action dated Dec. 6, 2023.
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Non-Final Office Action dated Oct. 4, 2023.
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Non-Final Office Action dated Oct. 13, 2023.
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Dec. 1, 2023.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Final Office Action dated Nov. 21, 2023.
U.S. Appl. No. 17/513,789, filed Oct. 28, 2021 Restriction Requirement dated Oct. 3, 2023.
U.S. Appl. No. 17/557,924, filed Dec. 21, 2021 Non-Final Office Action dated Nov. 3, 2023.
PCT/US2021/057135 filed Oct. 28, 2021 International Preliminary Report on Patentability dated May 2, 2023.
PCT/US2023/011173 filed Jan. 19, 2023 International Search Report and Written Opinion dated May 22, 2023.
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Notice of Allowance dated Apr. 24, 2023.
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Non-Final Office Action dated Jun. 8, 2023.
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Restriction Requirement dated Jun. 7, 2023.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Restriction Requirement dated Mar. 30, 2023.
U.S. Appl. No. 17/234,611, filed Apr. 19, 2021 Non-Final Office Action dated Apr. 23, 2024.
U.S. Appl. No. 17/234,611, filed Apr. 19, 2021 Restriction Requirement dated Jan. 18, 2024.
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Advisory Action dated Feb. 22, 2024.
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Final Office Action dated Mar. 13, 2024.
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Non-Final Office Action dated Feb. 14, 2024.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Advisory Action dated Feb. 14, 2024.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Non-Final Office Action dated Apr. 23, 2024.
U.S. Appl. No. 17/513,789, filed Oct. 28, 2021 Non-Final Office Action dated Jan. 9, 2024.
U.S. Appl. No. 17/554,978, filed Dec. 17, 2021 Non-Final Office Action dated Apr. 19, 2024.
U.S. Appl. No. 17/557,924, filed Dec. 21, 2021 Final Office Action dated Feb. 29, 2024.
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Non-Final Office Action dated Jun. 4, 2024.
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Notice of Allowance dated Jul. 17, 2024.
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Final Office Action dated May 6, 2024.
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Jul. 5, 2024.
U.S. Appl. No. 17/513,789, filed Oct. 28, 2021 Final Office Action dated Jul. 9, 2024.
Related Publications (1)
Number Date Country
20190255294 A1 Aug 2019 US
Provisional Applications (1)
Number Date Country
62109403 Jan 2015 US
Continuations (1)
Number Date Country
Parent 15008628 Jan 2016 US
Child 16398020 US